Nutanix, Inc. (NTNX) stock
NTNXNasdaqServices-Prepackaged SoftwareFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Sep 18, 2026Score 14/30100% below fair value
$56.52−2.42 (-4.11%)
Close on Nov 17, 2026Market cap $15.29BP/E –Yield –
Nutanix r&d expenses
Research and development expenses are spending on new products and technology.
Nutanix's R&D Expenses for the twelve months ending Jul 31, 2026 was $790.89M, up 7.3% year over year. For fiscal 2026 it was $790.89M, up 7.3% from the year before. Over ten years it grew 21.1% a year on average. The highest annual figure on record is $790.89M in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | $790.89M | +7.3% |
| FY2025 | Jul 31, 2025 | $736.82M | +15.3% |
| FY2024 | Jul 31, 2024 | $638.99M | +10.0% |
| FY2023 | Jul 31, 2023 | $580.96M | +1.4% |
| FY2022 | Jul 31, 2022 | $573.00M | +2.7% |
| FY2021 | Jul 31, 2021 | $558.01M | +0.7% |
| FY2020 | Jul 31, 2020 | $553.98M | +10.6% |
| FY2019 | Jul 31, 2019 | $500.72M | +59.6% |
| FY2018 | Jul 31, 2018 | $313.78M | +8.7% |
| FY2017 | Jul 31, 2017 | $288.62M | +148.0% |
| FY2016 | Jul 31, 2016 | $116.40M | +58.3% |
| FY2015 | Jul 31, 2015 | $73.51M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | $205.05M | +5.9% |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | $196.10M | +5.2% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | $202.26M | +10.7% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | $187.48M | +7.8% |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | $193.67M | +15.7% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $186.41M | +17.1% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $182.79M | +14.0% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $173.96M | +14.5% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $167.40M | +14.5% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $159.22M | +11.3% |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $160.40M | +12.7% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | $151.98M | +1.7% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $146.20M | +1.3% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $143.02M | +0.5% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $142.30M | +0.3% |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | $149.44M | +3.6% |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | $144.27M | +1.8% |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | $142.33M | -1.8% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | $141.87M | +4.6% |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | $144.27M | +6.2% |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | $141.72M | +4.7% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | $144.92M | +2.5% |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | $135.57M | -2.5% |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | $135.80M | -1.7% |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | $135.34M | +4.8% |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | $141.35M | +2.4% |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | $139.09M | +13.0% |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | $138.21M | +25.0% |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | $129.17M | +33.1% |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | $137.98M | +69.7% |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | $123.04M | +73.5% |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | $110.53M | +71.3% |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | $97.05M | +43.1% |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | $81.29M | +9.0% |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | $70.92M | +0.0% |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | $64.51M | -14.3% |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | $67.82M | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | $74.61M | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | $70.91M | – |
| Q1 FY2017CQ3 2016 | Oct 31, 2016 | $75.28M | – |
See a number that looks wrong?